Veracyte (VCYT) Depreciation & Amortization (CF) (2012 - 2026)

Veracyte has reported Depreciation & Amortization (CF) for 15 years, with the latest figure at $4.8 million in Q2 2026.

• Depreciation & Amortization (CF) for Q2 2026 came in at $4.8 million, down 11.86% year-over-year; the trailing twelve-month figure through Jun 2026 was $20.8 million (down 9.36% YoY), and the FY2025 annual result was $21.4 million, down 8.71% from the prior year.
• Depreciation & Amortization (CF) declined to $4.8 million in Q2 2026, from $5.4 million in the prior quarter.
• Over five years, Depreciation & Amortization (CF) peaked at $7.3 million in Q3 2023 and troughed at $4.8 million in Q2 2026.
• A 5-year average of $6.0 million and a median of $6.1 million in 2024 frame the typical range for Depreciation & Amortization (CF).
• The widest annual swing landed in 2022, when Depreciation & Amortization (CF) soared 157.1%; it then retreated 19.73% in 2024.
• A 5-year view of Depreciation & Amortization (CF) shows it stood at $6.6 million in 2022, then declined by 3.36% to $6.3 million in 2023, then declined by 1.31% to $6.3 million in 2024, then fell by 15.27% to $5.3 million in 2025, then decreased by 8.68% to $4.8 million in 2026.
• Per Business Quant data, the three most recent Depreciation & Amortization (CF) figures were $4.8 million in Q2 2026, $5.4 million in Q1 2026, and $5.3 million in Q4 2025.